Literature DB >> 8905301

Sexual behaviour and multiple infections in drug abusers.

R C Coppola1, G Masia, M L di Martino, G Carboni, E Muggianu, R Piro, P E Manconi.   

Abstract

We have studied the prevalence and the serological profile of HBV, HCV, HDV and HIV infections in 137 Italian subjects addicted to the intravenous use of heroine and correlated the virological findings with sexual behaviour. HBV and HCV viremia were also measured in 114 patients. Anti-HCV was detected in 81% of the addicts, and one or more markers of HBV infection were detected in 62.8% (4.4% were carriers of HBsAg, 58.4% had evidence of past HBV infection and 13.1% of the latter also had HDV markers). Anti-HIV was positive in 23.4%; 26% of those positive for anti-HCV and 4.6% of those positive for HBV markers had no other viral marker: none had only anti-HIV. HBV-DNA was negative in the carriers of HBsAg, and HCV-RNA was not detected in any of the HBsAg carriers who also had circulating anti-HCV. Overall, 34% of the anti-HCV positive addicts had HCV-RNA in their blood. The prevalence of the virus infection correlated with the duration of drug addiction but not with sexual behaviour, and sexual behaviour did not influence the acquisition of any virus. HCV infection was most frequent and probably the first infection to occur, but exposure to HBV was also common despite a low rate of HBsAg carriage. The prevalence of HDV infection was high (50%) in the HBsAg carriers, while the overall prevalence of HIV was lower (23%) than expected. Lack of HBV-DNA and HCV-RNA in carriers of HBV with anti-HCV in serum may indicate that HBV and HCV mutually inhibit their own replication.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8905301     DOI: 10.1007/bf00143992

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  16 in total

1.  Low prevalence of sexual transmission of hepatitis C virus in sex partners of seropositive intravenous drug users.

Authors:  C T Pachucki; J R Lentino; D Schaaff; M R Schaefer; C A Heynen; T J Holzer; G J Dawson; W Dorus
Journal:  J Infect Dis       Date:  1991-10       Impact factor: 5.226

2.  Risk reduction among intravenous drug users in Amsterdam under the influence of AIDS.

Authors:  J A van den Hoek; H J van Haastrecht; R A Coutinho
Journal:  Am J Public Health       Date:  1989-10       Impact factor: 9.308

3.  Heterosexual and homosexual transmission of hepatitis C virus: relation with hepatitis B virus and human immunodeficiency virus type 1.

Authors:  R Corona; G Prignano; A Mele; G Gentili; F Caprilli; E Franco; L Ferrigno; A Giglio; F Titti; C Bruno
Journal:  Epidemiol Infect       Date:  1991-12       Impact factor: 2.451

4.  DNA enzyme immunoassay: general method for detecting products of polymerase chain reaction.

Authors:  G Mantero; A Zonaro; A Albertini; P Bertolo; D Primi
Journal:  Clin Chem       Date:  1991-03       Impact factor: 8.327

5.  Sexual transmission of hepatitis C virus and its relation with hepatitis B virus and HIV.

Authors:  J Tor; J M Llibre; M Carbonell; R Muga; A Ribera; V Soriano; B Clotet; M Sabriá; M Foz
Journal:  BMJ       Date:  1990-11-17

6.  Hepatitis C virus infection in patients infected with the human immunodeficiency virus.

Authors:  C M Quan; M Krajden; G A Grigoriew; I E Salit
Journal:  Clin Infect Dis       Date:  1993-07       Impact factor: 9.079

Review 7.  Evidence for the effects of HIV antibody counseling and testing on risk behaviors.

Authors:  D L Higgins; C Galavotti; K R O'Reilly; D J Schnell; M Moore; D L Rugg; R Johnson
Journal:  JAMA       Date:  1991-11-06       Impact factor: 56.272

8.  Prevalence of hepatitis B virus markers among intravenous drug abusers in Stockholm: impact of heterosexual transmission.

Authors:  J Struve; K Käll; P Stendahl; G Scalia-Tomba; J Giesecke; O Weiland
Journal:  Scand J Infect Dis       Date:  1993

9.  Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV).

Authors:  M E Eyster; H J Alter; L M Aledort; S Quan; A Hatzakis; J J Goedert
Journal:  Ann Intern Med       Date:  1991-11-15       Impact factor: 25.391

10.  Prevalence of hepatitis C virus infections among heterosexuals with multiple partners.

Authors:  G J van Doornum; C Hooykaas; M T Cuypers; M M van der Linden; R A Coutinho
Journal:  J Med Virol       Date:  1991-09       Impact factor: 2.327

View more
  4 in total

1.  Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection.

Authors:  D M Patrick; M W Tyndall; P G Cornelisse; K Li; C H Sherlock; M L Rekart; S A Strathdee; S L Currie; M T Schechter; M V O'Shaughnessy
Journal:  CMAJ       Date:  2001-10-02       Impact factor: 8.262

2.  Prevalence, correlates, and viral dynamics of hepatitis delta among injection drug users.

Authors:  Lauren M Kucirka; Homayoon Farzadegan; Jordan J Feld; Shruti H Mehta; Mark Winters; Jeffrey S Glenn; Gregory D Kirk; Dorry L Segev; Kenrad E Nelson; Morgan Marks; Theo Heller; Elizabeth T Golub
Journal:  J Infect Dis       Date:  2010-09-15       Impact factor: 5.226

3.  Injection drug use and the hepatitis C virus: considerations for a targeted treatment approach--the case study of Canada.

Authors:  Benedikt Fischer; Emma Haydon; Jürgen Rehm; Mel Krajden; Jens Reimer
Journal:  J Urban Health       Date:  2004-09       Impact factor: 3.671

4.  Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and place.

Authors:  Holly Hagan; Enrique R Pouget; Don C Des Jarlais; Corina Lelutiu-Weinberger
Journal:  Am J Epidemiol       Date:  2008-10-09       Impact factor: 4.897

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.